sleep monitoring

Digital

As of 2024, more than one-third of American adults don't get enough sleep, and sleep satisfaction levels are worryingly low.

News

Sanofi has licensed rights to Kali's trispecific T-cell engager KT501, in trials for rheumatoid arthritis, in a deal valued at nearly $1.2bn.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.